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One of the most common splice variations are small exon length variations caused by the use of alternative donor or
acceptor splice sites that are in very close proximity on the pre-mRNA. Among these, three-nucleotide variations at so-
called NAGNAG tandem acceptor sites have recently attracted considerable attention, and it has been suggested that
these variations are regulated and serve to fine-tune protein forms by the addition or removal of a single amino acid.
In this paper we first show that in-frame exon length variations are generally overrepresented and that this
overrepresentation can be quantitatively explained by the effect of nonsense-mediated decay. Our analysis allows us
to estimate that about 50% of frame-shifted coding transcripts are targeted by nonsense-mediated decay. Second, we
show that a simple physical model that assumes that the splicing machinery stochastically binds to nearby splice sites
in proportion to the affinities of the sites correctly predicts the relative abundances of different small length variations
at both boundaries. Finally, using the same simple physical model, we show that for NAGNAG sites, the difference in
affinities of the neighboring sites for the splicing machinery accurately predicts whether splicing will occur only at the
first site, splicing will occur only at the second site, or three-nucleotide splice variants are likely to occur. Our analysis
thus suggests that small exon length variations are the result of stochastic binding of the spliceosome at neighboring
splice sites. Small exon length variations occur when there are nearby alternative splice sites that have similar affinity
for the splicing machinery.
Citation: Chern TM, van Nimwegen E, Kai C, Kawai J, Carninci P, et al. (2006) A simple physical model predicts small exon length variations. PLoS Genet 2(4): e45. DOI: 10.
1371/journal.pgen.0020045
Introduction
Anticipating that the sequencing and initial annotation of
the human [1,2] and mouse [3] genomes will not be able to
uncover all the complexities of mammalian gene structures,
several groups have focused on producing high-quality,
annotated transcript data such as the Riken Clone Collection
[4,5], the Mammalian Gene Collection [6], the NCBI Refer-
ence Sequence [7], and the NCBI unﬁnished high-throughput
cDNA sequences. In conjunction with genome sequences,
these data have revealed that alternative splicing [1,8–11],
alternative transcriptional initiation, and alternative poly-
adenylation [5,12,13] are extremely common, affecting over
70% of mammalian genes [14].
Many factors at the molecular level appear to play a role in
the regulation of splicing, from the recognition of the
primary splice signals by the components of the spliceosome,
to modulation of splicing via interactions of signaling and
RNA processing pathways with the spliceosome. More
speciﬁcally, the choice of splice site appears to be determined
by a combination of (1) the strength of the splice signal, i.e.,
the afﬁnity for the splicing machinery of the sequence around
the splice site, (2) structural constraints set on the inter-
actions of spliceosomal components by the lengths and
sequences of introns and exons and possibly by the secondary
structure of the mRNA, (3) the presence of enhancer or
repressor elements that may serve, respectively, to activate a
weak splice site or repress a strong one, and (4) the effective
concentrations of splicing factors such as SR proteins and
heterogeneous nuclear ribonucleoproteins that can be
regulated through post-translational modiﬁcations such as
phosphorylation [15]. The extensive literature elaborating on
the mechanisms of repression and activation of speciﬁc splice
sites has been reviewed by Smith and Valcarcel [16] and more
recently by Matlin et al. [17].
The high estimates of the frequency of alternative splicing
in human [8,14,18] and mouse [13] genes raise the question to
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production controlled and regulated by the cell, versus being
the result of inherent noise in the molecular process of
splicing. The molecular mechanisms mentioned in the
previous paragraph are all susceptible to noise, e.g., thermo-
dynamic noise, ﬂuctuations in the concentrations of splicing
factors, ﬂuctuations in elongation rates, and any other
ﬂuctuations that are not under the control of the cell. It is
thus clear that some of the splice variation observed in the
sequence data might simply be a result of noise [19]. At the
same time, one can easily imagine that many of the molecular
mechanisms just mentioned could be exploited by the cell to
regulate the expression of different splice variants under
different conditions.
In a previous study [13], we found that the second most
common form of splice variation (after ‘‘cassette’’ or
‘‘alternative’’ exons that are included in some but not all
transcripts) is a small change in exon length due to the use of
closely spaced alternative donor or acceptor sites. Intuitively,
the simplest explanation for these abundant small exon
length variations is that they are a result of noise in the
splicing process that causes the spliceosome to ‘‘slip’’ by a
small number of nucleotides, perhaps to a competing
neighboring splice site. However, as we previously reported
[13], three-nucleotide variations at tandem acceptor sites are
by far the most common among these small exon length
variations, and are much more common than any other exon
length variation. This seems to suggest that processes other
than simple noise must be causing these small in-frame shifts.
Indeed, in this context Hiller et al. [20] have proposed an
intriguing hypothesis, namely, that splice variations involving
only three nucleotides at so-called NAGNAG tandem accept-
or sites are introduced in a regulated manner to ‘‘ﬁne-tune’’
the protein sequence. More recently, these three-nucleotide
splice variations at NAGNAG sites have attracted consider-
able attention [21], including two papers [22,23] that
appeared after our submission of the current work.
Here we extensively study the statistics of small exon length
variations. We revisit our original hypothesis that these small
exon length variations are a result of noise in the splicing
process. In particular, we show that a combination of the
effects of nonsense-mediated decay (NMD) and a simple
physical model of the splicing machinery binding in a
stochastic manner to nearby splice sites can efﬁciently
explain all the observed statistics. In addition, we show that
our physical model can predict which NAGNAG tandem
acceptor sites are likely to undergo alternative splicing, which
will splice exclusively at the ﬁrst NAG, and which will splice
only at the second NAG.
Results
Splice Variations at Acceptor and Donor Sites
The use of alternative splice donor and acceptor sites leads
to exons whose length varies between transcripts. By far the
most common variation of this kind is a difference of precisely
three nucleotides at acceptor sites. To investigate the origin of
such variations we selected all exons that showed variation at
only one of their two splice sites, i.e., only at their acceptor site
or only at their donor site. For each exon with an alternative
acceptor (or donor) site we chose the most common splice site
as a reference site and counted the total number of alternative
splice events at different distances from the reference site.
Figure 1 shows the distribution of distances for both acceptor
and donor sites, calculated separately for coding, untranslated
region (UTR), and noncoding exons.
The ﬁrst thing to note is that the total number of
alternative acceptor sites is larger than the overall number
of alternative donor sites. This observation is consistent with
our previous reports on the FANTOM2 dataset [13] as well as
Figure 1. The Number of Splice Events Involving Alternative Donor and Acceptor Sites at a Specified Distance Relative to the Reference (Most
Commonly Used) Splice Site
The horizontal axis shows the distance from the reference splice site corresponding to each genomic exon for both donor sites (left) and acceptor sites
(right). The red lines correspond to coding exons, the black lines to UTR exons, and the blue lines to exons from non-protein-coding transcription units.
The vertical axis is shown on a logarithmic scale.
DOI: 10.1371/journal.pgen.0020045.g001
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Synopsis
It has recently become clear that splice variation affects most
mammalian genes. It is, however, less clear to what extent these
splice variations are functional and regulated by the cell as opposed
to simply a result of noise in the splicing process.
One of the most frequently observed forms of splice variation are
small variations in exon length in which the boundary of an exon is
shifted by small amounts between different transcripts. In this work
the authors study the statistics of these splice variations in detail,
and the results suggest that these variations are mostly the result of
noise in the splicing process. In particular, they propose a simple
physical model in which the last step of splicing involves the
sequence-specific binding of the splicing machinery to the splice
site. In this model, small length variations can occur when there are
nearby splice sites with comparable affinity for the splicing
machinery. The authors show that this model not only accurately
predicts the relative abundances of different splice variations but
also predicts which splice sites are likely to undergo small exon
length variations.with the observation made by Sugnet et al. [24] that conserved
mouse and human alternative acceptor splice sites are twice
as common as conserved alternative donor splice sites.
The second thing to note is that small length variations are
very common: 23.7% of all donor site variations and 43.7% of
all acceptor site variations involve ten or fewer nucleotides.
Thisissuggestiveofa‘‘noise’’ processinwhichthespliceosome
‘‘slides’’ a few nucleotides from its initially chosen position.
Preference for Reading Frame Preservation and NMD
Most of the exon length variations shown in Figure 1 are
not a multiple of three in length, and would therefore have
dramatic effects on translation whenever the splice boundary
overlaps the coding region (CDS). We will refer to exon
length variations as ‘‘in-frame’’ and ‘‘frame-shifting’’ depend-
ing on whether the change in exon length is or is not a
multiple of three. Figure 2 shows the fraction of in-frame and
frame-shifting variations for each category of splice sites. We
see that in-frame variations are overrepresented at the
acceptor boundaries of all exon types. In contrast, in-frame
variations are overrepresented at donor sites only of CDS
exons, and they amount to roughly 1/3 of the variations at the
donor sites of UTR and noncoding exons.
The different behavior of donor and acceptor sites is the
result of the very different distribution of very small exon
length variations of 1–4 nucleotides. As we show in detail
below, the frequencies of these very small exon length
variations at acceptor and donor sites are the result of the
different sequence composition of the ﬁrst few intronic bases
at donor and acceptor sites. If we focus on exon length
variations of more than four nucleotides, we ﬁnd that,
strikingly, both donor and acceptor splice sites show the
same pattern of in-frame variation across exon types (Figure
3). Namely, the frequency of in-frame variations at both
donor and acceptor splice sites of noncoding and UTR exons
is statistically indistinguishable from 1/3, which is what one
would expect by chance. Moreover, CDS exons show the same
overrepresentation (approximately 48%) of in-frame varia-
tions at both donor and acceptor splice sites.
One possible explanation for the overrepresentation of in-
frame variations could be that the sequences ﬂanking CDS
exon boundaries are biased such that alternative splice sites
occur more often in frame than out of frame. To test this
hypothesis we extracted the 100 nucleotides of the intronic
sequence ﬂanking the acceptor splice site of each exon that
shows length variation at the acceptor boundary and counted
the number of times an AG dinucleotide occurs at different
distances from the boundary. Similarly, we counted the
number of times the dinucleotide GT occurs at different
distances from donor sites of exons that show variation at
their donor site. We then determined the fraction of times
AG and GT occur in frame relative to the acceptor and donor
splice sites, respectively. The results are shown in Figure 4.
We see that, for both donor and acceptor sites, and for all
exon types, the frequency of in-frame occurrence of
dinucleotides that could form alternative splice sites is very
close to 1/3. It thus appears that biases in the sequence
composition ﬂanking CDS exons cannot explain the over-
representation of in-frame exon length variations at either
donor or acceptor sites.
The most plausible explanation for the statistics of the in-
frame variations is that NMD removes a fraction of tran-
scripts that have frame-shifting exon length variations in CDS
exons. The details of the NMD process are not completely
understood, but it is generally thought to function as follows
[25,26]. After the splicing process, the exon junction
complexes remain attached and are carried along with the
transcript. During a preliminary round of translation these
complexes are removed by the translation machinery. If any
Figure 2. Proportion of In-Frame Variations at Donor and Acceptor Splice
Sites That Are Located within CDS, UTR, and Noncoding Regions
This figure shows the fractions of alternative splice events that lead to an
in-frame shift with respect to the reference boundary at acceptor (39) and
donor (59) splice sites of CDS, UTR, and noncoding (NC) exons. The
estimated fraction is in the middle of the gray bar, with the gray bar
indicating two standard errors. The dashed line shows the fraction 1/3
that would be expected by chance.
DOI: 10.1371/journal.pgen.0020045.g002
Figure 3. Proportion of In-Frame Variations of More Than Four
Nucleotides at Donor and Acceptor Sites Located within CDS, UTR, and
Noncoding Regions
This figure shows the fractions of alternative splice events that lead to an
in-frame shift with respect to the reference boundary at acceptor (39) and
donor (59) splice sites of CDS, UTR, and noncoding (NC) exons, when only
splice events that are more than four nucleotides shifted with respect to
the reference boundary are considered. The two rightmost columns
show the fractions when the data from all CDS exons and all non-CDS
exons are pooled.
The estimated fraction is in the middle of the gray bar, with the gray bar
indicating two standard errors. The dashed line shows the fraction 1/3
that would be expected by chance.
DOI: 10.1371/journal.pgen.0020045.g003
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away from the stop codon, the transcript is targeted by NMD.
Thus, frame-shifting length variation in CDS exons leads to
premature stop codons, which in turn increase the chance of
the transcript being targeted by NMD. In contrast, the
boundaries of noncoding and UTR exons already do not
overlap the CDS; therefore, the shifts that occur here do not
alter the probability of the transcript being targeted by NMD.
In summary, it is reasonable to assume that some fraction
of all frame-shifting exon length variations at CDS exons are
targeted by NMD, and that only a fraction f survive NMD. Let
us assume that before NMD a fraction qi of all exon length
variations at CDS exons are in frame. Since in-frame exon
length variations are not affected by NMD, and a fraction f of
frame-shifting variations make it past NMD, it follows that
the observed frequency qo of in-frame exon length variations
in CDS exons is given by
qo ¼
qi
qi þ fð1   qiÞ
: ð1Þ
There is no reason to believe that the fraction qi of in-
frame variations before NMD is different from 1/3. This
assumption is supported by the fact that the fraction of
potential acceptor and donor dinucleotides within 100
nucleotides of exon boundaries is 1/3 for both CDS and
non-CDS exons (see Figure 4). We thus assume that qi ¼ 1/3
for CDS exons as well. Since qo ¼ 0.484 (Figure 3) for CDS
exons, it then follows that f ¼ 0.53. That is, the data suggest
that slightly more than 50% of the transcripts that contain a
frame-shifting exon length variation in a CDS exon survive
the NMD process.
Exon Length Variations of 1–4 Nucleotides and NAGNAG
Acceptor Boundaries
We now turn to the exon length variations of 1–4
nucleotides, whose relative frequencies are shown in Figure
5. To take into account the effects of NMD we have rescaled
the numbers of variations of length three by a factor f¼0.53,
as calculated in the previous section. Moreover, since the
frequencies of such variations at CDS, UTR, and noncoding
exons are very similar, we have pooled the data for each type
Figure 4. Proportion of Putative Donor (GT) and Acceptor (AG) Splice
Sites That Are Located In-Frame Relative to the Splice Sites in CDS, UTR,
and Noncoding Regions
This figure shows the fraction of AG dinucleotides that occur at distance
that is a multiple of three in the first 100 intronic bases upstream of
acceptor (39) splice sites of exons that show splice variation at their
acceptor sites, and the fraction of GT dinucleotides that occur at a
distance that is a multiple of three in the first 100 intronic bases
downstream of donor (59) splice sites of exons that show splice variations
at their donor sites. Occurrences of AG or GT within the first four bases
flanking the splice sites were not counted. The estimated fraction is in the
middle of the gray bar, with the gray bar indicating two standard errors.
Thedashedlineshowsthefraction1/3thatwouldbeexpectedbychance.
DOI: 10.1371/journal.pgen.0020045.g004
Figure 5. The Distribution of Alternative Splice Events That Are Shifted by One, Two, Three, or Four Nucleotides with Respect to the Reference Splice
Site
The two left panels show the observed distributions at acceptor sites (above) and donor sites (below). The estimated relative frequency is in the middle
of the gray bar, with the width of the gray bar corresponding to two standard errors. The panels on the right show the predicted relative frequency of
alternative splice events of lengths 1–4 based on the splice site WMs and the sequences around exon boundaries that show splice variation.
DOI: 10.1371/journal.pgen.0020045.g005
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Small Exon Length Variationsof splice site (Table S1 lists these distributions separately for
each exon type). Figure 5 thus shows estimates of the relative
frequencies of splice variations of lengths 1–4 nucleotides
before NMD, which appear to be very different for donor
compared to acceptor splice sites. At donor sites, the most
common variations are shifts of one or four nucleotides while
in-frame variations of length three are rare. In contrast, at
acceptor sites the in-frame variations of length three are
highly overrepresented, as we have already reported in our
analysis of the FANTOM2 dataset [13]. The very large
majority (94%) of these three-nucleotide variations involve
tandem acceptor sites whose sequence is of the form
NAGNAG. These have been the topic of a recent paper by
Hiller et al. [20], who proposed that the role of such variations
is to ‘‘ﬁne-tune’’ protein forms by addition/deletion of a
single amino acid. That is, Hiller et al. [20] suggested that
these NAGNAG sites have been speciﬁcally selected to
provide the cell with alternative protein forms, and to
express these different protein forms in a regulated manner.
If the three-nucleotide variations at NAGNAG acceptor
sites were indeed important for ﬁne-tuning protein forms,
then one would expect these variations to be more abundant
at CDS than at non-CDS exons. However, once we correct for
the overrepresentation of all in-frame variations due to NMD,
this is not what we observe. As shown in Table S1, the relative
frequency of three-nucleotide variations is not signiﬁcantly
different at CDS, UTR, and noncoding exons. In addition, the
NAGNAG sequence motif is not overrepresented at acceptor
sites of CDS exons. On the contrary, the frequency of
NAGNAG sites at the splice boundaries of UTR and
noncoding exons is 6.7% compared to only 5.9% at the
boundaries of coding exons. This is statistically signiﬁcantly
lower in a v
2 test at a p-value of 0.00014. Thus, NAGNAG
sequences are in fact a little less frequent at the acceptor sites
of CDS exons than at those of non-CDS exons.
We next investigated the evolutionary conservation of
NAGNAG acceptor sites. If the NAGNAG sites that show
splice variation were explicitly selected to do so, one would
expect them to be better conserved evolutionarily than
NAGNAG sites in exons that show no splice variation. To test
this hypothesis, we extracted the human sequences that
correspond to NAGNAG sites in mouse from the pairwise
mm5–hg17 alignments provided by the University of Cal-
ifornia Santa Cruz Genome Bioinformatics group (http://
hgdownload.cse.ucsc.edu/goldenPath/mm5/vsHg17/axtNet).
We found that the proportion of mouse NAGNAG acceptor
sites that have corresponding human NAGNAG sites (allowing
the nucleotides at the N positions to vary) is in fact slightly
higher in invariant exons (59.5%) than in variant exons
(54.7%) (3,998/6,715 versus 273/499, v
2 test, p ¼ 0.04). The
frequency of perfectly conserved NAGNAG sites (where the
nucleotidesattheNpositionsareconservedaswell)is45.7%in
invariant exons and 42.7% in variant exons, which statistically
is not signiﬁcantly different. Thus, NAGNAG sites of variant
exons are not more conserved in evolution than NAGNAG
sites of invariant exons. If anything they are less conserved
than NAGNAG sites of invariant exons. We thus cannot ﬁnd
any evidence that the abundance of three-nucleotide varia-
tions at acceptor sites is due to speciﬁc selection, or that it is
related to the coding potential of the transcript.
We instead consider the much simpler hypothesis that the
small exon length variations are a result of inherent noise in
the splicing process. We hypothesize that the ﬁnal step in the
process of splice site selection involves the sequence-speciﬁc
binding of the splicing machinery to the mRNA. This binding
process is subject to thermal noise just like any physicochem-
ical process. Whenever multiple ‘‘binding sites’’ with com-
parable afﬁnity occur near each other, the splicing machinery
may bind to these alternative sites in a stochastic fashion, and
this will lead to small shifts of the splice site.
To test this hypothesis we ﬁrst constructed computational
models of the sequence speciﬁcity of the splicing machinery
at acceptor and donor sites. Speciﬁcally, we gathered
acceptor and donor boundaries of invariant exons and
reconstructed weight matrices (WMs) of length 12 from the
six intronic bases and the six exonic bases ﬂanking each
boundary. These WMs are shown in Figure 6. The WMs
demonstrate the well conserved GT dinucleotide immediately
following the donor boundary and the AG dinucleotide
immediately preceding the acceptor boundary. The WMs also
show the known preference for a second GT dinucleotide
four nucleotides downstream of the donor site, the polypyr-
imidine tract 5–6 nucleotides upstream of the acceptor site,
and the preference for a cytosine immediately preceding the
AG of the acceptor site.
We now assume that the probability of the splicing
machinery binding to a particular sequence is proportional
to the probability of observing that sequence when sampling
from the WM representing that boundary. That is, we assume
that the probability P(i) that the splicing machinery will bind
Figure 6. WMs Representing the Sequence Specificity of the Spliceosome at Invariant Donor and Acceptor Splice Sites
WMs have been constructed from six exonic and six intronic nucleotides flanking each type of splice site. The relative sizes of the letters are
proportional to the frequency wa
i of each nucleotide a at position i. The total height in each column is given by the information score I¼Rawa
i log(4wa
i).
DOI: 10.1371/journal.pgen.0020045.g006
PLoS Genetics | www.plosgenetics.org April 2006 | Volume 2 | Issue 4 | e45 0610
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probability of the local sequence si 6si 5...siþ4siþ5 under the WM
PðiÞ¼ P
k¼5
k¼ 6
wk
siþk; ð2Þ
where wk
a is the frequency of base a at position k of the WM,
and i is the location of the putative splice site.
For the donor site WM we collected all exons that show
variation at the donor site and calculated the probabilities P(i)
at the positions that are shifted by between one and four
nucleotides (either to the left or right) with respect to the
observed splice site. By summing all P(i) that correspond to
shiftsofthesamelength,wecalculated therelativefrequencies
of length variations of lengths 1–4 that our model predicts.
These predictions are shown in the lower right panel of Figure
5. In the same way, using the acceptor site WM and the
sequences ﬂanking acceptor sites in exons that show variation
at their acceptor site, we calculated the relative frequencies of
variations of lengths 1–4 that our model predicts at acceptor
sites. These predictions are shown in the upper right panel of
Figure 5. Given the simplicity of our model, its predictions of
the relative abundances of different length variations match
the data surprisingly well. At the donor sites, it correctly
predicts that shifts of length one and four are the most
abundant and that shifts of length three are the least
abundant. At the acceptor sites, the model predicts relative
abundances that are quantitatively very close to the observed
abundances. In particular, the predicted abundance of three-
nucleotide variations is within 1% of the observed abundance.
We thus see that a very simple model of splice site selection
based on the sequence speciﬁcity of the splicing machinery at
each splice site can correctly predict the relative abundances
of small exon length variations. This further supports the
hypothesis that these small exon length variations are mostly
the result of inherent noise in the splicing process.
Local Sequence Distinguishes Variant Tandem Acceptor
Sites from Nonvariant Tandem Acceptor Sites
Ifourmodelforthesmallexonlengthvariationsiscorrect,it
should also be possible to predict, from the sequence, which
acceptor sites are most likely to be prone to three-nucleotide
length variations. To this end we focused on all acceptor sites
that show the sequence pattern NAGNAG at their splice site.
We collected all acceptor sites with sequence NAGNAG
(irrespective of which of the two NAG sequences is used as
splicesite)andthenselectedonlythosesitesforwhichthereare
at least two transcripts in the data. We then counted, for each
NAGNAGsite,howmanytimesweobservedsplicingattheﬁrst
and how many times at the second NAG site. Based on these
counts we separated the NAGNAG sites into three categories:
those that splice only at the ﬁrst NAG, those that splice only at
the second NAG, and those that splice at both NAGs.
We then investigated to what extent we could predict the
category of each NAGNAG site by using the WM constructed
from the invariant acceptor sites. We again assumed that the
binding afﬁnity of the splicing machinery to a putative
acceptor site sequence is proportional to the log-likelihood of
the putative acceptor site sequence given the acceptor site
WM. If we additionally assumed that the probability of
splicing occurring at the different NAG sites is proportional
to the equilibrium frequencies with which the splicing
machinery binds at these sites, then the category of a
NAGNAG site is only a function of the difference in log-
likelihood of the neighboring acceptor sites.
Figure 7 shows the fractions of NAGNAG sites that splice
only at the ﬁrst NAG, only at the second NAG, or at both
NAGs as a function of the log-likelihood difference of the two
sites. The results are quite striking. We see that, using the
simple WM model, one can reasonably accurately predict
which NAGNAG sites splice only at the ﬁrst NAG, which
splice only at the second, and which show three-nucleotide
length variations. Whenever the log-likelihood of the ﬁrst site
is larger by ﬁve or more than the log-likelihood of the second
site, then splicing virtually always occurs at the ﬁrst site only.
Similarly, if the log-likelihood of the second site is larger by
ﬁve or more than the log-likelihood of the ﬁrst site, then
splicing virtually always occurs at the second site. When there
is almost no difference in the log-likelihood of the two sites,
then in the large majority of examples one observes splicing
at both sites. These results further support our hypothesis
that splice site selection is simply based on the afﬁnity of the
splice site for the splicing machinery, and that small exon
length variations occur whenever there are neighboring
splice sites with comparable afﬁnity.
Discussion
Recent large-scale sequencing efforts have made clear that
the great majority of mammalian genes are subject to splice
variation, and that some genes show a very large number of
different transcript forms. One of the most basic questions to
ask about these splice variations is to what extent they are
regulated by the cell rather than being the result of noise in
the molecular process or of other ﬂuctuations that are not
controlled by the cell. We investigated this issue for small
exon length variations caused by the alternative usage of
nearby acceptor and donor sites.
Small exon length variations are the second most common
form of splice variation. Among these, three-nucleotide
variations at tandem acceptor sites containing a NAGNAG
sequence pattern are by far the most common. It has been
Figure 7. Dependency of the Frequency of Alternative Splicing at
NAGNAG Sites on the Relative Likelihood of the Two Putative Acceptor
Sites
The figure shows the fraction of all NAGNAG boundaries that splice only
at the first NAG (red), only at the second NAG (green), or at both NAGs
(blue) as a function of the log-likelihood difference of the first and
second putative splice sites for the acceptor site WM.
DOI: 10.1371/journal.pgen.0020045.g007
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forms through these subtle splice variations [20]. However, we
were unable to ﬁnd any evidence that NAGNAG sites are
either under speciﬁc evolutionary selection or are more
abundant at coding exons than at noncoding exons. In
contrast, we collected and compared a number of statistics on
observed small exon length variations, and showed that all
these statistics can be accurately explained by the combined
effect of NMD and the stochastic binding of the splicing
machinery to competing nearby splice sites.
Our analysis of the relative abundances of exon length
variations of ﬁve and more nucleotides at donor and acceptor
sites of CDS, UTR, and noncoding exons strongly suggests
that NMD targets about 50% of frame-shifting exon length
variations at CDS exons. This effect partly explains the
overrepresentation of three-nucleotide variations in the data.
When the effects of NMD are taken into account, donor and
acceptor sites show very distinct relative abundances of small
exon length variations, with an overrepresentation of shifts of
length one and four at donor sites, and an overrepresentation
of shifts of length three at acceptor sites. However, shifts of
length three at acceptor sites are not more abundant at CDS
exons than they are at UTR and noncoding exons. This
observation again supports our conjecture that the abun-
dance of three-nucleotide shifts is special to the speciﬁcs of
splicing at acceptor sites and is not related to the coding
potential of the exon.
To explain the relative abundances of these small exon
length variations we introduced a model that assumes that the
last step in splice site selection involves the sequence-speciﬁc
binding of the splicing machinery to a splice site and that the
probability of splicing occurring at a particular site is
proportional to the afﬁnity of the splice site sequence for
the splicing machinery. In this model, small exon length
variations can occur when there are multiple binding sites
with comparable afﬁnity near each other. Our model is similar
to the scanning model proposed by Smith et al. [27] for the
selection of 39 splice sites: the spliceosome recognizes and
binds the region of the branch point and polypyrimidine
sequence, but once there, it can still ‘‘see’’ a limited stretch of
sequence in which competing splice sites may be present. The
relative frequencies with which these competing splice sites
are used in the splicing reaction are determined by the afﬁnity
of the spliceosome for the sequences of the different sites.
From the splicesites of invariant exonswe constructed WMs
representing the sequence speciﬁcity of the splicing machi-
nery at donor and acceptor sites. We used these WMs to
predict the relative frequencies of small exon length varia-
tions from the sequences ﬂanking the observed splice sites of
variant exons and found that the predictions accurately
reproduce the observed relative abundances. For example, the
relatively high abundance of shifts of four nucleotides at
donor sites is explained by the common occurrence of a GT
pattern at positionþ5 of the intron [13,28]. The relatively high
abundance of three-nucleotide variations at acceptor splice
sites is explained by the fact that the WM of the acceptor sites
strongly disfavors a guanine at position 3 (directly upstream
of the AG) and that positions 5, 6, and further upstream are
part of the polypyrimidine tract that disfavors the occurrence
of purines in general. Therefore, whenever an alternative AG
dinucleotide does occur, it is almost always at position 3 and
not at  1, 2, or  4.
Apart from explaining the relative abundances of small
exon length variations at both donor and acceptor sites, our
simple model also predicts, with reasonable accuracy, which
NAGNAG acceptor sites show splice variation and which do
not. We showed that when one of the two neighboring sites
has much higher afﬁnity than the other, one observes splicing
almost exclusively at the site with the higher afﬁnity. When
the neighboring sites have similar afﬁnity, three-nucleotide
variations are observed in the large majority of cases.
Materials and Methods
Transcript mapping and splice analysis. The transcripts used in the
study consist of the 102,797 FANTOM3 mouse full-length cDNAs [29]
and 52,070 GenBank mouse mRNAs. We mapped all these transcripts
to the mm5 assembly of the mouse genome available from the
University of California Santa Cruz.
For the identiﬁcation of splice variants we used a new implemen-
tation of the automated splicing analysis pipeline that we developed
for the FANTOM2 project [13]. Brieﬂy, we ﬁrst mapped all cDNAs to
the mouse genome using our novel spliced alignment algorithm, SPA
[30], which produces better quality alignments than other commonly
used cDNA-to-genome alignment programs. In particular, it has
fewer alignment errors around splice boundaries, and has a better
coverage of the 59 and 39 ends of the cDNAs. The details of the
comparisons of SPA’s mappings to those of other methods are
described in van Nimwegen et al. [30].
To avoid biases from transcripts that are badly mapped we selected
only those transcripts that had at least 75% of their nucleotides
mapped to the genome, with at least 95% identity or fewer than ten
mismatches in each exon. This procedure yielded 129,655 mapped
transcripts, which we clustered such that the mapping of each
transcript in a cluster shared at least one exonic nucleotide on the
same strand with at least one other transcript in the cluster [11,13].
We obtained 42,023 clusters (transcription units) that we analyzed for
splice variation. We refer the reader to Zavolan et al. [13] for the
details of the annotation procedure. Brieﬂy, all exons whose genomic
mappings overlap were clustered into ‘‘genomic exons.’’ For each
genomic exon we then compared the set of exons corresponding to it
to identify splice variation.
For our analysis of exon length variations we extracted all genomic
exons that show only variation at their donor splice site and all exons
that show only variation at their acceptor splice site. For each such
genomic exon we then extracted the set of all ‘‘clean’’ exons
corresponding to it. These ‘‘clean’’ exons were selected based on
the following criteria: (1) the ﬁrst and last ten nucleotides of every
clean exon must be perfectly aligned (no mismatches or gaps) to the
genome, and (2) the ﬁrst ten nucleotides of the ﬂanking exon(s) must
be perfectly aligned. We used the FANTOM3 and GenBank
annotation of CDSs to separate the exon boundaries of the clean
exons into boundaries that overlap with the CDS, boundaries that are
located in the UTRs of transcripts that have a CDS annotated, and
boundaries of exons from noncoding transcription units. A non-
coding transcription unit has no CDS annotated for any of its
corresponding transcripts.
For each genomic exon with variation only at the acceptor site or
only at the donor site we then determined the number of times each
alternative boundary was observed and took the most abundant
boundary as the ‘‘reference boundary.’’ We then counted the total
number of times other boundaries were observed for each of these
exons, and recorded the distances of these alternative boundaries
from the reference boundary. Finally, we constructed from these
counts the histograms of the number of observed exon length
variations as a function of the distance to the reference boundary for
each boundary type and each class of exon. The total numbers of
observed exon length variations for donor sites were 871 in CDS
exons, 524 in UTR exons, and 117 in noncoding exons, and for
acceptor sites were 1,620 in CDS exons, 366 in UTR exons, and 109 in
noncoding exons.
The relatively low number of variations in noncoding exons is a
result of the fact that transcripts from noncoding transcription units
in general have far fewer exons than do coding transcripts. In
addition, there are many transcripts for which no CDS is annotated
but that occur in a transcription unit that does contain at least one
transcript with an annotated CDS. We exclude these transcripts
because it is unclear whether they are indeed noncoding or whether
their CDS has simply not been annotated.
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Small Exon Length VariationsFor every exon that has variation only at its acceptor boundary we
collectedalltranscriptsthatcontainthisexonandextractedtheﬁrst100
intronic nucleotides upstream of the acceptor site for this exon.
Similarly, for every exon with variation only at its donor boundary we
collectedalltranscriptsthatcontainthisexonandextractedtheﬁrst100
nucleotides downstream of the donor site in each of these transcripts.
Selection of the sequences used for constructing the WMs for
donor and acceptor splice sites. We used the full set of clean invariant
exons to extract sequences at the acceptor and donor splice sites. We
removed all sequences that contained ambiguous characters and
obtained a set of 130,827 sequences in each set. We wanted to use the
sequences of these invariant exons to construct WMs for the acceptor
and donor site sequences. However, since we also wanted to score
NAGNAG sites for these WMs, we split the set of all invariant exons
into two halves and used only the ﬁrst half to construct the WMs of the
six intronic and six exonic nucleotides ﬂanking the splice site. The
other half we used for extracting NAGNAG sites of invariant exons.
Extraction of NAGNAG acceptor splice sites and log-likelihood
histogram. From the second half of acceptor site sequences of
invariant exons just described we collected all boundaries that have a
NAGNAG sequence. There were 2,444 cases of NAGNAG invariant
exons that splice at the ﬁrst NAG and 228 cases of NAGNAG
invariant exons that splice at the second NAG. The set of variant
exons with NAGNAG sites consisted of all clean exons that contain a
NAGNAG motif at their acceptor site and whose only splice variation
involves the use of alternative acceptor sites precisely at the
NAGNAG boundary. We obtained 404 exons with such variant
NAGNAG acceptor sites.
For each of these NAGNAG sites we calculated the difference in
log-likelihood of the tandem putative acceptor sites for the acceptor
site WM. We then ordered all 3,076 NAGNAG sites by the log-
likelihood difference (from small to large) and calculated the average
log-likelihood difference and fraction of sites variant, invariant
splicing at the ﬁrst NAG, and invariant splicing at the second NAG in
consecutive groups of 50 sites. That is, the horizontal value of the
leftmost data points of the red, green, and blue curves in Figure 7
were obtained by averaging the log-likelihood differences of the ﬁrst
50 NAGNAG sites, and the vertical values were obtained by
calculating the fraction of variant NAGNAG sites (blue), invariant
NAGNAG sites splicing at the ﬁrst boundary (red), and invariant
NAGNAG sites splicing at the second boundary (green) among those
ﬁrst 50 NAGNAG sites. Similarly, the second leftmost set of data
points was obtained by calculating the same averages and fractions
over NAGNAG sites 11 through 60, the third set of points over
NAGNAG sites 21 through 70, etc.
Supporting Information
Table S1. The Relative Frequencies and Two Standard Errors of Exon
Length Variations of Length 1–4 at Donor and Acceptor Sites of
Different Exon Types
Note that, in order to correct for NMD, the number of variations of
length three has been multiplied by 0.53 and rounded to the nearest
integer.
Found at DOI: 10.1371/journal.pgen.0020045.st001 (11 KB PDF).
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